Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 3 Triple Negative Breast Neoplasms 2 Melanoma 2 Unilateral Breast Neoplasms 1 Resectable Esophageal Cancer 1 Neoplasms 1 Multiple Myeloma 1 Lung Neoplasms 1 Locally Advanced Pancreatic Adenocarcinoma 1 Leukemia, Plasma Cell 1 Inflammatory Breast Neoplasms 1 Gliosarcoma 1 Glioblastoma 1 Ganglioneuroblastoma 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

pembrolizumab 25 Cyclophosphamide 20 Nivolumab 13 Doxorubicin 13 Carboplatin 10 Surveys and Questionnaires 9 Paclitaxel 9 Exercise 9 atezolizumab 8 Vincristine 8 Rituximab 8 Radiotherapy 8 Prednisone 8 Dexamethasone 8 Bevacizumab 8 venetoclax 7 fludarabine 7 Pemetrexed 7 Fluorouracil 7 Docetaxel 7 Blood Specimen Collection 7 lenvatinib 6 dostarlimab 6 cemiplimab 6 budigalimab 6 Oxaliplatin 6 Cisplatin 6 durvalumab 5 Leucovorin 5 Lenalidomide 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Neoplasms × Colony-Stimulating Factors × Clear all

NCT05421897 2026-01-29

RAPID

Children's Hospital Los Angeles

Phase 1 Active not recruiting

Neoplasms, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡